WHO ICTRP trial
A study on reducing the incidence of postherpetic neuralgia
ChiCTR2400084014 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400084014 |
|---|---|
| Public title | A study on reducing the incidence of postherpetic neuralgia |
| Scientific title | A study on reducing the incidence of postherpetic neuralgia by epidural injection of medical ozone through intervertebral foramen |
| Primary sponsor | Deyang People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Herpes zoster neuralgia |
| Interventions | experimental group:Medical ozone intervertebral foramen epidural injection;Control group:False injection |
| Registration date | May 9, 2024 |
| Target size | experimental group:35;Control group:35 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: